Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
Latest News

Cadila buys 50% stake of Zydus BSV Pharma

On Thursday Cadila Healthcare acquired 50 per cent stake from Bharat Serum and Vaccines in its JV firm.

“The company has purchased 50 percent shares of Zydus BSV Pharma (Zydus BSV) from Bharat Serums and Vaccines and now Zydus BSV has become 100 percent subsidiary of Cadila Healthcare,” Cadila Healthcare said in a BSE filing.

Zydus BSV Pharma is a joint venture company of Cadila Healthcare and biotech firm Bharat Serum and Vaccines (BSV). It founded in the year of 2005.

The Financial details of the transaction are not known yet. Zydus BSV Pharma develops, manufactures and markets non infringing and proprietary novel drug delivery system of approved anti cancer agents for global markets.

Get Daily Prediction & Stocks Tips On Your Mobile